circul
rna
may
result
excess
cell
damag
acut
viral
infect
interact
vascular
endotheli
cell
despit
obviou
clinic
implic
associ
presenc
circul
rna
patholog
effect
endotheli
cell
govern
molecular
mechan
still
fulli
elucid
analyz
effect
doubl
strand
rna
primari
human
pulmonari
arteri
endotheli
cell
hpaec
effect
natur
synthet
doublestrand
rna
dsrna
hpaec
investig
use
transendotheli
electr
resist
molecul
traffick
calcium
ca
homeostasi
gene
express
prolifer
studi
furthermor
morpholog
mechan
chang
cell
caus
synthet
dsrna
follow
insitu
atom
forc
microscopi
vascularendotheli
cadherin
factin
stain
result
indic
exposur
hpaec
synthet
dsrna
led
function
deficit
reflect
morpholog
mechan
chang
increas
permeabl
endotheli
monolay
hpaec
treat
synthet
dsrna
accumul
phase
cell
cycl
addit
prolifer
rate
cell
presenc
synthet
dsrna
significantli
decreas
furthermor
found
natur
synthet
dsrna
modul
ca
signal
hpaec
inhibit
sarcoendoplasm
ca
atpas
serca
involv
regul
intracellular
ca
homeostasi
thu
cell
growth
even
upon
synthet
dsrna
stimul
silenc
preserv
endotheli
monolay
integr
data
identifi
novel
mechan
dsrna
disrupt
endotheli
barrier
function
may
relev
inflammatori
process
endotheli
function
essenti
vascular
integr
endothelium
provid
barrier
regul
vascular
tension
involv
angiogenesi
haemostasi
local
system
inflamm
howev
impair
endotheli
function
lead
cellular
damag
increas
endotheli
permeabl
loss
epitheli
barrier
function
endogen
rna
releas
circul
rna
like
virusassoci
doubl
strand
rna
dsrna
may
contribut
develop
endotheli
dysfunct
endotheli
cell
express
tolllik
receptor
activ
dsrna
activ
affect
cell
homeostasi
caus
chang
function
well
inflammatori
gene
express
level
cellular
level
dsrna
induc
signal
cascad
lead
receptor
upregul
organ
level
repeat
longterm
administr
synthet
dsrna
caus
inflamm
lead
impair
lung
function
mice
howev
biolog
activ
circul
extracellular
rna
poorli
understood
recent
extracellular
rnainduc
activ
vegf
shown
lead
increas
permeabl
cerebr
endotheli
cell
main
compon
blood
brain
barrier
hyperperm
occur
due
exposur
cell
total
rna
synthet
analogu
dsrna
polyinosinicpolycytidyl
acid
poli
c
lead
disintegr
adheren
junction
endotheli
permeabl
regul
function
ca
process
rise
intracellular
ca
ec
occur
ca
influx
releas
sarcoendoplasm
reticulum
ser
result
plasma
membraneloc
ca
channel
activ
maintain
ca
homeostasi
cell
ca
store
refil
sermembraneloc
sarcoendoplasm
reticulum
ca
atpas
serca
serca
encod
three
homolog
gene
human
pulmonari
arteri
endotheli
cell
hpaec
isoform
express
howev
serca
play
import
role
ca
homeostasi
vital
cell
cycl
control
prolifer
regul
cellular
permeabl
well
present
studi
investig
altern
pathway
dsrna
primari
hpaec
chang
cell
morpholog
permeabl
cellular
junction
mechan
properti
ca
homeostasi
character
furthermor
assess
effect
natur
synthet
dsrna
gene
express
prolifer
hpaec
serca
human
pulmonari
arteri
endotheli
cell
hpaec
obtain
lonza
allendal
new
jersey
cultur
accord
manufactur
instruct
endotheli
specif
media
vasculif
lifelin
chang
everi
third
day
cell
passag
use
experi
endotheli
phenotyp
regularli
check
von
willebrand
factor
express
poli
c
purchas
amersham
pharmacia
ldna
fermenta
bhq
receiv
sigma
doublestrand
rna
sens
antisens
qiagen
total
cellular
rna
isol
hpaec
rneasi
mini
kit
qiagen
phosphoakt
akt
antibodi
obtain
cell
signal
technolog
inc
chemic
dissolv
dilut
desir
concentr
experiment
solut
contain
mm
nacl
kcl
cacl
mgcl
glucos
hepe
ph
set
solut
freshli
prepar
day
experi
store
use
experi
carri
room
temperatur
unless
otherwis
state
measur
cellular
barrier
properti
hpaec
grown
confluenc
semiperm
insert
teer
measur
use
endohm
chamber
connect
evom
resist
meter
world
precis
instrument
sarasota
usa
teer
valu
record
everi
min
first
hour
addit
hour
timepoint
treatment
mgml
poli
c
mgml
dsrna
mg
ml
totalrna
mgml
ldna
control
solut
measur
carri
resist
blank
filter
insert
fill
control
media
subtract
background
valu
total
resist
cultur
insert
assess
permeabl
chang
endotheli
monolay
hpaec
grown
confluenc
semiperm
insert
incub
h
mgml
poli
c
mg
ml
dsrna
mgml
totalrna
mgml
ldna
mm
mm
bhq
control
solut
vehicl
control
treatment
fitclabel
dextran
ad
upper
compart
insert
vitro
vascular
permeabl
assay
kit
chemicon
fluoresc
solut
bottom
well
measur
fluoresc
plate
reader
lex
nm
lem
nm
optima
bmg
labtech
quantit
rtpcr
stimul
agent
total
cellular
rna
hpaec
isol
rneasi
mini
kit
qiagen
protocol
purif
total
rna
cell
use
spin
technolog
follow
cat
noid
addit
dnase
digest
rna
isol
carri
rnasefre
dnaseset
qiagen
cat
noid
agil
bioanalyz
agil
rna
nano
assay
protocol
use
quantifi
concentr
puriti
isol
total
rna
total
cellular
rna
isol
endotheli
cell
convert
cdna
use
revertaid
h
minu
first
strand
cdna
synthesi
kit
fermenta
pcr
amplif
perform
appli
biosystem
use
follow
primer
gapdh
sybr
green
master
mix
qiagen
amplif
perform
triplic
mean
threshold
cycl
ct
read
use
gene
express
quantifi
rel
housekeep
gene
gapdh
normal
express
level
untreat
control
sampl
deltadelta
ct
method
hpaec
seed
chamber
slide
grown
confluenc
treat
h
mgml
poli
c
mgml
dsrna
mgml
totalrna
mgml
ldna
mm
mm
bhq
kept
untreat
control
cell
fix
buffer
contain
ml
phosphat
buffer
salin
solut
pb
ph
mg
na
hpo
mg
nah
po
ml
methanol
ml
formaldehyd
slide
wash
prewarm
hepe
buffer
salin
solut
hbss
min
room
temperatur
rt
wash
cell
min
pb
cover
min
nm
glycerol
rt
min
wash
step
pb
perform
follow
permeabil
min
rt
afterward
min
pb
wash
step
perform
cell
block
min
bsa
pb
rt
wash
min
primari
antibodi
vecadherin
dilut
abcam
dilut
zyme
ad
cell
min
rt
wash
min
cell
incub
rt
min
goat
antimous
antibodi
conjug
dilut
molecular
probe
dark
final
cell
counterstain
dapi
identifi
nuclear
dna
duplic
process
without
primari
antibodi
serv
neg
control
fluoresc
imag
use
zeiss
invert
epifluoresc
microscop
phalloidin
stain
cell
fix
formaldehyd
min
permeabil
use
aceton
min
block
bovin
serum
albumin
min
coverslip
incub
molecular
probe
mount
perform
antifad
embed
medium
biomeda
distribut
signal
imag
use
nikon
eclips
photomicroscop
epifluoresc
capabl
connect
digit
camera
spot
rt
ke
protein
extract
prepar
hpaec
ripa
buffer
contain
proteaseinhibitor
phosphataseinhibitor
tablet
roch
vienna
austria
equival
amount
protein
resolv
sd
polyacrylamid
gel
protein
transfer
nitrocellulos
membran
nonspecif
antibodi
bind
block
incub
mv
nonfat
dri
milk
powder
tbst
mm
triscl
ph
mm
nacl
vv
tween
room
temperatur
h
afterward
blot
incub
overnight
dilut
primari
antibodi
wash
membran
tbst
buffer
incub
dilut
horseradishperoxidas
conjug
antiigg
secondari
antibodi
h
room
temperatur
specif
immunoreact
signal
detect
enhanc
chemiluminesc
ecl
amersham
freiburg
germani
cell
cultur
gelatin
coat
mm
glass
cover
slip
reach
confluenc
treat
h
mgml
poli
c
mgml
dsrna
mgml
ldna
mgml
total
rna
left
untreat
control
cover
slip
load
mmoll
dark
min
follow
wash
step
experiment
solut
previous
describ
min
singl
glass
cover
slip
mount
stage
zeiss
invert
epifluoresc
microscop
coupl
polychrom
v
monochrom
till
photon
germani
light
sourc
seal
temperaturecontrol
imag
chamber
warner
instrument
usa
perfus
prewarm
solut
fluoresc
imag
obtain
altern
excit
nm
emit
light
collect
nm
aircool
andor
ixon
camera
andor
technolog
ireland
measur
made
everi
background
fluoresc
record
cover
slip
subtract
calcul
acquir
imag
store
process
offlin
tillvis
softwar
till
photon
germani
ca
calcul
describ
grynkiewicz
et
al
maxim
minim
ratio
valu
determin
end
experi
first
treat
cell
mmoll
ionomycin
maxim
ratio
chelat
free
ca
mmoll
egta
minim
ratio
cell
respond
ionomycin
discard
cell
stimul
mm
histamin
mm
bhq
select
serca
blocker
presenc
absenc
extracellular
ca
incub
h
mgml
poli
c
mgml
dsrna
mgml
ldna
mgml
total
rna
control
solut
measur
perform
asylum
head
molecular
forc
probe
control
asylum
research
santa
barbara
ca
usa
driver
program
mfp
xop
written
igor
pro
softwar
version
wavemetr
lake
oswego
usa
head
mount
zeiss
axiovert
invert
optic
microscop
cell
cultur
gelatineco
mm
diamet
glass
cover
slip
confluenc
sampl
mount
stage
microscop
contact
mode
imag
forc
curv
acquisit
perform
afterward
cell
treat
mgml
poli
c
left
untreat
control
imag
forc
curv
acquisit
repeat
everi
min
hour
imag
solut
gold
coat
silicon
nitrid
rectangular
cantilev
use
biolev
olympu
optic
co
ltd
tokyo
japan
imag
solut
determin
young
moduli
made
previous
report
cell
plate
densiti
cellswel
fb
medium
plate
allow
adher
overnight
concentrationdepend
effect
h
incub
poli
c
dsrna
totalrna
ldna
bhq
growth
prolifer
hpaec
determin
h
thymidin
incorpor
index
dna
synthesi
h
thymidin
mciwel
ad
last
h
h
incub
cell
harvest
transfer
filterpl
radioact
measur
use
betacount
measur
cellcycl
depend
amount
dna
per
cell
propidiumiodid
stain
perform
methanolfix
hpaec
h
incub
poli
c
control
solut
cell
trypsin
centrifug
min
wash
ml
pb
pellet
resuspend
centrifug
min
dissolv
ml
pb
cell
ml
ice
cold
methanol
ad
min
data
analysi
dna
protocol
use
small
interf
rna
sirna
commerci
synthes
santa
cruz
biotechnolog
neg
control
nonsilenc
rna
sictl
control
sirnaa
santa
cruz
biotechnolog
target
human
gene
product
use
either
nm
sictl
nm
mix
hpaec
ml
basic
nucleofector
solut
basic
endotheli
cell
nucleofector
kit
lonza
mixtur
electropor
accord
manufactur
instruct
knockdown
confirm
quantit
rtpcr
western
blot
specif
primer
antibodi
permeabl
measur
fluoresc
label
dextran
vecadherin
stain
perform
h
post
transfect
numer
valu
given
mean
sd
n
cell
intergroup
differ
assess
factori
analysi
varianc
post
hoc
fisher
least
signific
differ
test
student
ttest
p
valu
consid
signific
live
cell
ca
imag
data
analysi
basal
level
ca
determin
averag
valu
first
second
curv
afterward
histamineinduc
ca
peak
height
subtract
baselin
well
plateau
durat
ca
respons
quantifi
plateau
durat
time
maximum
ca
peak
height
intracellular
ca
declin
basal
level
determin
block
potenc
poli
c
hpaec
prolifer
concentrationinhibit
curv
construct
fcsinduc
hpaec
prolifer
presenc
differ
drug
concentr
media
prolifer
valu
given
presenc
poli
c
fraction
fcsinduc
prolifer
absenc
poli
c
normalis
valu
fit
mean
nonlinear
leastsquar
method
equat
h
c
drug
concentr
concentr
give
halfmaximum
effect
h
hill
coeffici
hill
coeffici
less
set
one
account
bind
stoichiometri
doublestrand
rna
dsrna
synthet
analogu
poli
c
significantli
decreas
electr
resist
increas
permeabl
confluent
human
pulmonari
arteri
endotheli
hpaec
monolay
shown
figur
primari
hpaec
incub
dsrna
poli
c
hour
transendotheli
electr
resist
teer
measur
figur
ldna
tolllik
receptor
ligand
use
control
signific
decreas
teer
observ
alreadi
hour
treatment
suggest
dsrna
poli
c
disrupt
integr
endotheli
monolay
contrast
incub
ldna
signific
effect
consist
traffick
fitclabel
dextran
molecul
confluent
endotheli
monolay
significantli
increas
h
dsrna
poli
c
total
rna
applic
figur
control
respect
h
incub
ldna
signific
effect
control
elong
poli
c
treat
cell
appear
rearrang
fiber
structur
observ
actin
stain
figur
b
promin
live
cell
atom
forc
microscopi
imag
figur
repres
amplitud
imag
control
hpaec
show
regular
cell
shape
seen
figur
wherea
elong
cell
detect
imag
taken
h
poli
c
treat
cultur
figur
poli
c
treatment
also
associ
time
depend
stiffen
cell
figur
young
moduli
hpaec
determin
direct
forc
measur
distinct
point
nuclear
region
number
cell
shown
figur
signific
increas
young
moduli
kpa
kpa
upon
h
poli
c
treatment
observ
figur
integr
intercellular
junction
investig
vascular
endothelialcadherin
vecadherin
zonula
occluden
stain
continu
membran
stain
vecadherin
show
coloc
two
protein
figur
h
poli
c
treatment
caus
disrupt
endotheli
barrier
integr
vecadherin
membran
stain
either
disappear
becam
discontinu
figur
next
investig
phosphatidylinositol
driven
regul
endotheli
permeabl
prolifer
poli
c
treatment
result
upregul
hpaec
figur
method
howev
vecadherin
stain
figur
show
cumul
effect
poli
c
blocker
total
disappear
protein
cell
membran
consist
fitclabel
dextran
traffic
significantli
increas
hour
effect
addit
poli
c
effect
lead
increas
amount
transmit
fluoresc
dextran
molecul
figur
addit
prolifer
hpaec
block
similar
poli
c
effect
inhibit
compound
administ
togeth
figur
tabl
mm
histamineinduc
peak
ca
concentr
cell
tabl
contrast
h
dsrna
incub
significantli
prolong
mm
histamineinduc
ca
signal
absenc
figur
presenc
extracellular
calcium
figur
similar
result
observ
poli
c
wherea
ldna
incub
effect
figur
prolong
ca
signal
figur
suggest
dsrna
treatment
caus
delay
clearanc
cytoplasm
ca
necessari
replic
investig
effect
dsrna
sarcoendoplasm
reticulum
caatpas
serca
gene
express
analysi
perform
serca
isoform
present
hpaec
show
signific
decreas
mrna
express
h
poli
c
treatment
figur
next
effect
poli
c
dsrna
treatment
phosphoryl
phospholamban
endogen
inhibitor
serca
assess
h
treatment
signific
decreas
phospholamban
phosphoryl
observ
figur
h
inhibitori
effect
dsrna
serca
pump
expect
investig
serca
blocker
bhq
induc
dosedepend
inhibit
hpaec
prolifer
figur
effect
similar
dsrna
poli
c
figur
bhq
treatment
led
disrupt
vecadherin
stain
similar
poli
c
figur
effect
accompani
increas
endotheli
permeabl
figur
point
decreas
endotheli
barrier
function
next
investig
effect
poli
c
sirna
silenc
hpaec
figur
observ
increas
permeabl
upon
mgml
poli
c
treatment
sictl
hpaec
significantli
reduc
silenc
figur
parallel
confoc
microscop
imag
reveal
knock
caus
less
vecadherin
signal
loss
upon
h
poli
c
stimul
compar
sictl
figur
silenc
confirm
previou
find
obtain
serca
blocker
bhq
altogeth
data
suggest
synthet
dsrna
treatment
alter
function
serca
inhibit
cell
prolifer
induc
arrest
hpaec
contribut
endotheli
dysfunct
major
function
vesselform
endotheli
cell
maintain
bloodtissu
barrier
viral
rna
identifi
pathogen
factor
differ
pulmonari
diseas
circul
rna
may
lead
pulmonari
endotheli
dysfunct
thu
increas
endotheli
permeabl
precis
mechan
circul
rna
induc
endotheli
barrier
disrupt
lung
complet
understood
yet
present
studi
address
novel
pathway
dsrna
effect
primari
human
pulmonari
arteri
endotheli
cell
hpaec
data
show
natur
dsrna
treatment
significantli
decreas
electr
resist
indic
disrupt
hpaec
monolay
integr
similar
effect
could
observ
wide
use
synthet
dsrnaanalog
poli
c
incub
ldna
caus
signific
permeabl
chang
indic
specif
dsrna
effect
dsrna
poli
c
treatment
mimic
viral
infect
result
line
previou
observ
bluetongu
virusinfect
human
primari
microvascular
endotheli
cell
ec
monolay
disrupt
effect
dsrna
confirm
use
fluoresc
label
dextran
traffick
show
stimul
either
poli
c
total
rna
dsrna
result
increas
transfer
dextran
amount
suggest
signific
loss
endotheli
barrier
function
tight
isol
monolay
endotheli
cell
accomplish
junction
structur
like
adheren
tight
junction
major
compon
mainten
monolay
integr
belong
transmembran
protein
famili
cadherin
vascular
endotheli
cell
express
membran
vascular
endotheli
cadherin
vecadherin
member
famili
poli
c
incub
decreas
vecadherin
signal
point
disrupt
cellcel
contact
monolay
similar
decreas
report
result
viru
infect
human
umbil
vein
endotheli
cell
observ
similar
decreas
protein
upon
poli
c
treatment
furthermor
result
indic
junction
protein
contribut
dissoci
intercellular
contact
also
actin
reorgan
poli
c
treat
cell
present
intens
peripher
actin
stain
accompani
cellular
shape
chang
visibl
immunofluoresc
pictur
similar
cytoskelet
rearrang
shown
induc
h
bluetongu
viru
infect
primari
human
microvascular
endotheli
cell
although
author
report
recoveri
electr
resist
actinvecadherin
stain
h
case
either
dsrna
poli
c
treatment
experi
could
explain
differ
human
lung
microvascular
arteri
endotheli
cell
investig
possibl
involv
pathway
poli
c
induc
permeabl
structur
chang
test
effect
blocker
permeabl
prolifer
junction
stain
shown
pathway
could
involv
dsrna
induc
signal
inde
observ
upregul
receptor
upon
poli
c
treatment
block
result
increas
hpaec
permeabl
decreas
prolifer
disrupt
vecadherin
stain
primari
hpaec
block
addit
effect
poli
c
point
independ
mechan
action
howev
other
report
involv
dsrna
signal
studi
mammalian
heterologuo
express
system
use
higher
concentr
poli
c
could
confirm
inhibitori
effect
serca
express
previous
report
inhibitor
serca
depend
calcium
handl
howev
effect
downregul
isoform
addit
point
independ
mechan
action
similar
effect
observ
hpaec
permeabl
prolifer
structur
chang
caus
inflammatori
stimuli
may
lead
dissoci
cellcel
junction
lead
widen
intercellular
space
facilit
transendotheli
flux
observ
similar
structur
rearrang
light
microscopi
poli
c
treat
cell
present
morpholog
chang
elong
shape
insitu
atom
forc
microscopi
afm
imag
forc
measur
detect
structur
chang
endotheli
cell
singl
cell
level
endotheli
barrierdisrupt
agent
report
caus
chang
cytoskelet
mechan
hpaec
afm
imag
cell
treat
poli
c
show
elong
morpholog
shape
furthermor
poli
c
treatment
also
led
approxim
stiffen
cell
line
observ
effect
barrierdisrupt
agent
hpaec
chang
mechan
properti
cell
lead
disturb
disrupt
cellcel
contact
may
contribut
endotheli
dysfunct
critic
factor
regular
endotheli
function
ca
homeostasi
data
suggest
besid
structur
chang
poli
c
dsrna
also
affect
endotheli
ca
homeostasi
acut
administr
either
poli
c
dsrna
result
ca
respons
hour
treatment
led
significantli
prolong
histamineinduc
ca
respons
without
affect
basal
ca
level
focus
intracellular
ca
mobil
key
player
ca
store
refil
sarcoendoplasm
reticulum
caatpas
serca
proper
regul
vital
normal
cell
function
inhibitori
effect
poli
c
serca
suggest
increas
durat
histamineinduc
signal
observ
presenc
absenc
extracellullar
ca
observ
decreas
phospholamban
phosphoryl
upon
poli
c
dsrna
treatment
contribut
enhanc
block
serca
function
phospholamban
neg
regul
serca
function
phospholamban
phosphoryl
caus
dissoci
serca
remov
inhibit
rtpcr
show
decreas
express
isoenzym
serca
upon
poli
c
treatment
howev
upon
dsrna
treatment
chang
gene
express
could
observ
thu
data
indic
dsrna
regul
serca
express
like
synthet
analogu
poli
c
nonetheless
caus
decreas
phospholamban
phosphoryl
furthermor
serca
blocker
bhq
induc
dosedepend
inhibit
hpaec
prolifer
decreas
vecadherin
stain
increas
transendotheli
transport
similar
effect
dsrna
poli
c
sirna
silenc
hpaec
confirm
figur
prolong
histamineinduc
ca
plateau
hpaec
poli
c
incub
accompani
serca
downregul
phospholamban
dephosphoryl
repres
trace
mm
histamin
induc
intracellular
ca
rise
ca
free
ca
c
condit
show
prolong
decay
intracellular
ca
level
hpaec
h
poli
c
red
line
dsrna
green
line
total
rna
orang
line
treatment
control
ldna
effect
blue
line
arrow
indic
applic
histamin
b
histamin
induc
transient
ca
plateau
durat
significantli
longer
case
treatment
compar
control
untreat
sampl
absenc
b
presenc
mm
extracellular
ca
bar
graph
show
express
e
f
isoform
sarcoendoplasm
reticulum
ca
atpas
pump
result
independ
experi
perform
triplic
compar
vehicl
control
g
phospholamban
phosphoryl
upon
h
poli
c
dsrna
treatment
pplb
phosphoryl
phospholamban
h
bar
graph
repres
pplbatubulin
ratio
independ
western
blot
experi
compar
vehicl
control
involv
serca
poli
c
induc
endotheli
dysfunct
data
indic
poli
c
induc
arrest
hpaec
inhibit
function
serca
vital
cell
cycl
control
rat
aortic
endotheli
cell
decreas
serca
activ
result
delay
phase
transit
cell
cycl
serca
dysfunct
also
report
follow
exposur
pancreat
beta
cell
cytokin
howev
experi
function
also
express
serca
decreas
upon
poli
c
treatment
could
result
disturb
cell
cycl
regul
exposur
hpaec
poli
c
fact
disturb
regular
cell
cycl
furthermor
dose
timedepend
accumul
hpaec
observ
increas
accompani
decreas
number
cell
phase
indic
cell
cycl
arrest
addit
poli
c
treatment
result
inhibit
prolifer
increas
apoptosi
figur
method
ca
homeostasi
cell
alter
affect
serca
pump
without
chang
apoptosi
conclud
poli
c
caus
ca
mishandl
due
serca
downregul
function
inhibit
therebi
lead
arrest
final
inhibit
hpaec
prolifer
conclus
data
suggest
exposur
synthet
doublestrand
rna
modul
ca
signal
human
pulmonari
arteri
endotheli
cell
inhibit
ca
extrud
pump
sarcoendoplasm
ca
atpas
cell
cycl
cell
monolay
integr
affect
result
accumul
hpaec
phase
cell
cycl
circul
dsrna
due
reduc
phospholamban
phosphoryl
may
alter
intracellular
ca
homeostasi
thu
cell
growth
lead
endotheli
cell
dysfunct
tempt
hypothes
circul
extracellular
rna
eg
viral
infect
act
barrier
disrupt
agent
contribut
develop
human
pulmonari
vascular
dysfunct
figur
bar
graph
repres
gene
fold
chang
compar
untreat
control
hour
poli
c
ldna
stimul
tif
figur
bar
graph
repres
percentag
apoptot
cell
measur
pi
annexin
v
stain
upon
hour
stimul
stauro
staurosporin
compar
control
method
quantit
rtpcr
apoptosi
measur
hpaec
docx
